Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
4 Positives For Johnson & Johnson
10:28am, Tuesday, 23'rd Jul 2024
Johnson & Johnson might be the worst performing big pharma stock YTD, but there's upside possible for it in the remainder of 2024. Revenue growth guidance was upgraded and even with a downgrade in EPS
Johnson & Johnson: Seriously Undervalued At Peak Pessimism
12:19pm, Monday, 22'nd Jul 2024
Johnson & Johnson, the pharmaceutical giant with a 3.21% dividend yield, released financial results for Q2 2024 that exceeded my expectations. Its oncology franchise revenue was $5.09 billion for the
10 Dividend Stocks for Midyear
12:18pm, Monday, 22'nd Jul 2024
These dividend stocks to buy offer attractive yields at cheap prices.
Should You Pick Johnson & Johnson Stock At $155 After Q2 Beat?
09:30am, Monday, 22'nd Jul 2024
Johnson & Johnson (NYSE: JNJ) recently reported its Q2 results, with revenues aligning and earnings exceeding our estimates. The company reported revenue of $22.4 billion and adjusted earnings of $2.8
Phase 4 SPRAVATO® monotherapy data shows rapid improvement in depressive symptoms at ~24 hours, sustained through at least 4 weeks Monotherapy submission builds on more than a decade of research, 31
3 Blue-Chip Stocks to Buy for Christmas in July
04:45pm, Friday, 19'th Jul 2024
The Dow Jones Industrial Index is made up of 30 of the largest, publicly traded companies trading on either the New York Stock Exchange (NYSE) or the Nasdaq. These companies are known as blue-chip sto
Don't Overthink It - Bet On Safety And Predictability
07:00am, Friday, 19'th Jul 2024
Howard Marks discusses the impact of debt on survival during economic challenges. Debt amplifies movements in investments and businesses, leading to potential survival challenges during economic downt
Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst
02:51pm, Thursday, 18'th Jul 2024
Wednesday, Johnson & Johnson JNJ reported a second-quarter adjusted EPS of $2.82, up 10.2% Y/Y, beating the consensus of $2.70.
3 Dividend Stocks That Demand Investor Attention
02:09pm, Thursday, 18'th Jul 2024
Dividend stocks pay dividends to their shareholders, representing a portion of the company's profits. Not all companies offer dividends.
These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results
12:12pm, Thursday, 18'th Jul 2024
Johnson & Johnson JNJ reported better-than-expected second-quarter earnings on Wednesday.
Is Johnson & Johnson a Buy Now?
05:40am, Thursday, 18'th Jul 2024
Johnson & Johnson reported results from the second quarter of 2024 on Wednesday, July 17. U.S. pharmaceutical sales grew by nearly 9% year over year in the second quarter.
2 Magnificent S&P 500 Dividend Stocks Down 19% and 41% to Buy and Hold Forever
04:25am, Thursday, 18'th Jul 2024
Starbucks is experiencing weak sales this year, but it has plenty of opportunities to keep growing over the long term. Johnson & Johnson's focus on allocating capital to high-return opportunities has
Why Johnson & Johnson Stock Was a Winner on Wednesday
06:14pm, Wednesday, 17'th Jul 2024
The healthcare sector mainstay unveiled its latest set of quarterly results. Its second-quarter headline figures comfortably beat the consensus-analyst estimates.
J&J MedTech Navigates Headwinds, Eyes Growth Surge in Second Half of 2024
05:39pm, Wednesday, 17'th Jul 2024
Johnson & Johnson's (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J, remains committed to
Stock Of The Day: Johnson & Johnson Hits Crucial Roadblock — Can It Break Through?
03:12pm, Wednesday, 17'th Jul 2024
Investors loved the Johnson & Johnson JNJ earnings report. The stock is trading much higher, but it has stalled out around an important resistance level.
